React4life & Prodeco Pharma: Organ-on-Chip partnership to accelerate evidence‑based botanicals
React4life is a global leader in organ‑on‑chip (OOC) technologies and is excited to announce a new strategic partnership with Prodeco Pharma, an Italian healthcare company specialized in phytotherapy.
A Synergy of Technological Innovation and Natural Tradition
React4Life is an Italian biotech company that develops and commercializes proprietary organ-on-chip platforms (based on the patented MIVO® technology), designed for preclinical and translational research, and applicable across multiple fields, including, by way of example, oncology, nutraceuticals, and dermocosmetics. The MIVO® organ-on-chip platform enables the in vitro reproduction of human physiological conditions, allowing predictive and animal-free assesment of the efficacy and safety of molecules, materials, and formulations.
Prodeco Pharma, with its long‑standing experience in the development and standardization of botanical extracts, contributed to its phytotherapeutic expertise and its vision of a natural approach grounded in balance, safety, and science.
“We are thrilled to collaborate with Prodeco Pharma, a cutting‑edge company in natural and phytotherapeutic innovation,” said Maurizio Aiello, CEO of React4life. “The use of our MIVO® human-on-chip platform demonstrates how this technology can support high-quality botanicals research and speed up the evaluation of efficacy and safety for new solutions, including natural products”.
“We believe that this partnership will be extremely valuable to our innovation strategies, because it proves how the combination of advanced science and experience-based knowledge can improve people’s well-being. With React4life’s support, we aim to design innovative products with strong scientific evidence, expression of our propensity and responsibility to provide high-quality products” added Giovanni Catania, CEO of Prodeco Pharma.
Benefits for People, Medicine, and Research
Use of herbal supplements is on the rise around the world. Through this collaboration and evidence-based botanicals research, it is possible to validate traditional uses and to facilitate new natural remedies development. React4life’s organ‑on‑chip enables:
– early identification of critical issues, reducing the risk of unexpected negative outcomes in the subsequent phases of product development;
– acceleration of the screening phase for phytotherapeutic formulations, shortening development timelines from years to months;
– Support for data‑driven decision‑making, increasing acceptance of botanical dietary supplements by healthcare professionals and improving confidence in recommending natural and “green” products.
Consequently, Prodeco Pharma’s innovation can accelerate the research of evidence and the entire healthcare ecosystem can benefit from a more sustainable approach, based on cutting‑edge technologies that cut down animal testing and improve result transparency.
“This synergy demonstrates how OOC platforms can validate traditional uses and efficacy of botanicals, turn the promise of safer natural remedies into concrete reality, guaranteeing a future where people receive appropriate solutions, healthcare professionals have more reliable data and industry can innovate responsibly” concludes Maurizio Aiello/React4life.
Boilerplate – React4life
React4life is a deep-tech biotech company founded by Silvia Scaglione and Maurizio Aiello, scientists with decades of experience at the Italian National Research Council (CNR). Their mission is to bring the best scientific results to the market, transforming research into real-world innovations that benefit society. React4life develops and commercializes organ‑on‑chip platforms that replicate the functions and interactions of human tissues in controlled environments. Its solutions enable researchers and biotech firms to reduce drug‑development time and cost, improve the predictive power of pre‑clinical stages, and contribute to more ethical and sustainable medicine. With a broad product portfolio capable of reproducing diverse physiological and pathological conditions across human tissues, React4life supports companies developing new therapies, supplements, medical devices, probiotics, dermocosmetic formulations, and flavor & fragrance products. Every assay and device developed by React4life is validated through rigorous methodologies, as confirmed by numerous peer-reviewed scientific publications. The company serves an international customer base, including several multinational groups with revenues exceeding one billion euros.
Boilerplate – Prodeco Pharma
Prodeco Pharma is an Italian family-owned company that operates internationally in the field of natural medicine through research, formulation, and distribution of solutions designed to promote the physiological processes that regulate the body’s balance, keeping the body and mind healthy. For over 35 years, Prodeco Pharma has promoted the adoption of a healthy lifestyle as part of a holistic approach to health and well-being, combining this with the development of safe, effective and innovative phytotherapeutic formulations. Founded in 1988 in Castelfranco Veneto, in 2016 the Company began a process of internationalization that has resulted in the establishment of two foreign branches, based in Spain and Germany. Prodeco Pharma offers a comprehensive portfolio of over 150 products, including medical devices, cosmetics, and dietary supplements, all developed in accordance with the principles of naturalness, effectiveness, quality, and innovation, and supported by numerous scientific evidence. Finally, the Company’s commitment goes beyond the product. It actively supports environmental and social sustainability projects, promoting a 360° health approach through awareness raising, training, and the involvement of consumers and business partners.

Press Contacts
React4life – Press Office
E‑mail: press@react4life.com
Phone: +39 010 0980110
Website: www.react4life.com
Prodeco Pharma – Communications Office
E‑mail: press@prodecopharma.com
Phone: +39 0423 744161
Website: www.prodecopharma.com

